Meeting Coverage:

American Academy of Ophthalmology

AAO: 2019

Autonomous AI in Ophthalmology

Show Description +

Ophthalmologists know how to treat diabetic retinopathy, yet about 60,000 patients lose their sight per year as a result of the disease. Michael D. Abramoff, MD, PhD, discusses the use of AI in primary care to provide earlier diagnoses of diabetic retinopathy, and what the future may hold for AI in diagnosing other ophthalmic diseases as well as those outside the eye.

Posted: 10/02/2019

Up Next

CXL for Infectious Keratitis

Farhad Hafezi, MD, PhD, FARVO


MIGS and Medications

Alex Huang, MD

Controlling Wound Healing Following PRK

Farhad Hafezi, MD, PhD, FARVO

A New Anti-VEGF Option

J. Fernando Arevalo, MD, PhD, FACS

PANORAMA Study Data

Rishi P. Singh, MD

Gene Therapy for Wet AMD

Szilard Kiss, MD

ABC to Block VEGF-A Isoforms

Charles C. Wykoff, MD, PhD

Surgery for Viral Retinitis

J. Fernando Arevalo, MD, PhD, FACS

Iridocorneal Endothelial Syndrome

Lauren S. Blieden, MD

Advanced Diagnostics in Refractive Surgery: Epithelial Mapping and Phakic IOL Sizing

Dan Z. Reinstein, MD, MA(Cantab), FRCSC, DABO, FRCOphth, FEBO

Efficacy of Presbyond for the Correction of Presbyopia

Dan Z. Reinstein, MD, MA(Cantab), FRCSC, DABO, FRCOphth, FEBO

Autonomous AI in Ophthalmology

Ophthalmologists know how to treat diabetic retinopathy, yet about 60,000 patients lose their sight per year as a result of the disease. Michael D. Abramoff, MD, PhD, discusses the use of AI in primary care to provide earlier diagnoses of diabetic retinopathy, and what the future may hold for AI in diagnosing other ophthalmic diseases as well as those outside the eye.

Posted: 10/02/2019


Please log in to leave a comment.

More From AAO: 2019 Coverage

A New Anti-VEGF Option

J. Fernando Arevalo, MD, PhD, FACS